ABCB1 and sarcoidosis: Since no such studies of MDR TH17 cells in sarcoidosis exist, investigation of P-glycoprotein expressing TH17 cells is warranted since MDR TH17 cells could indicate ineffective glucocorticoid therapy in patients with this cell subset and thus be potentially used as a clinical treatment decision making tool in sarcoidosis patients.